| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |